Stay in the know
We’ll send you the latest insights and briefings tailored to your needs
18 1月 2017
Insight
London
Our regular patent and pharma update aims to keep you informed of recent developments in United Kingdom and European law relating to patents and the pharmaceutical industry.
The UPC may be open for business in 2017 despite Brexit
A look at recent UPC developments following the June 2016 referendum Read more
How "obvious to try" are routine steps in clinical research?
Examining recent English court decisions on "obvious to try" assessments carried out in the context of clinical trials in the pharmaceutical industry Read more
A unified standard for the requirement of plausibility across different grounds of patent invalidity
Understanding the meaning of "plausible" in English patent law by referring to the guidance provided in recent case decisions Read more
Deploying competition law defences in patent infringement
Noting the increasingly vigilant attitude of competition law authorities to look into settlement/licensing agreements and the deployment of competition law defences in English patent trials Read more
Click here for summary tables with key points from recent court decisions
Key contacts
Legal Notice
The contents of this publication are for reference purposes only and may not be current as at the date of accessing this publication. They do not constitute legal advice and should not be relied upon as such. Specific legal advice about your specific circumstances should always be sought separately before taking any action based on this publication.
© Herbert Smith Freehills 2025